Invention Grant
- Patent Title: 3, 10, and 12a substituted tetracycline compounds
- Patent Title (中): 3,10和12a取代的四环素化合物
-
Application No.: US12727114Application Date: 2010-03-18
-
Publication No.: US08481513B2Publication Date: 2013-07-09
- Inventor: Upul Bandarage , Jackson Chen , Mohamed Y. Ismail , Mark L. Nelson , Kwasi Ohemeng
- Applicant: Upul Bandarage , Jackson Chen , Mohamed Y. Ismail , Mark L. Nelson , Kwasi Ohemeng
- Applicant Address: US MA Boston
- Assignee: Paratek Pharmaceuticals, Inc.
- Current Assignee: Paratek Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: McCarter & English, LLP
- Main IPC: A01N37/18
- IPC: A01N37/18 ; A61K31/65 ; C07C43/00
Abstract:
The present invention pertains to novel 3, 10, and/or 12a-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Public/Granted literature
- US20100190756A1 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS Public/Granted day:2010-07-29
Information query
IPC分类:
